SGLT2 ANTAGONISTS TO DELAY OVARIAN AGING
WO2026035622A1 · Application publication visible
immortal.lifeExplore source-linked longevity patent families and topic connections associated with the applicant name OKLAHOMA MEDICAL RESEARCH FOUNDATION.
This independent page groups EPO bibliographic records in which this name appears as an applicant or assignee. It is not a corporate profile, ownership opinion, portfolio valuation or ranking.
WO2026035622A1 · Application publication visible